Role of Systemic Therapy for Advanced/Metastatic Gastric Carcinoma in First Line Treatment: A Systematic Review and Network Meta-Analysis (PODIUM PRESENTATION)
Mohsen Yaghoubi |Associate Principal Scientist, Certara
Immunotherapies and/or targeted agents in advanced/metastatic gastric cancer (A/MGC) offer more treatment combinations than standard systemic chemotherapies. A systematic literature review (SLR) and network meta-analysis (NMA) was conducted to evaluate the relative efficacy and safety of first-line systemic therapies in A/MGC.
Review of Health Technology Assessment (HTA) and recommendations for the introduction of higher-valency Pneumococcal Conjugated Vaccine (PCV) in 4 European countries, the United Kingdom (UK), and the United States (US).
Roxane Noharet-Koenig, Katarzyna Lasota, Pascaline Faivre, Edith Langevin |
USE of Biomarkers in Health Care: What Health Economic Methods Are Used to Evaluate Them?
Neeser K, Koller L, Mueller E |
Joint Scientific Consultation (JSC) and Joint Clinical Assessment (JCA) - A Better Road to Access?
Elvira Mueller, Kurt Neeser |
Real-world patterns of care and outcomes among advanced cervical cancer patients in England: retrospective analysis of the NCRAS datasets, 2012-2019
Khachatryan A, Doobaree I, Banon T |
Changes to Early Access Scheme in France: Early Learnings for Orphan Drugs
Jelena Sostar, Pauline Herscu and Pascaline Faivre |
A Novel Medical Technology for Rapid Molecular Diagnostics (Nicking Enzyme Amplification Reaction [NEAR]) - A Systematic Literature Review, Meta-Analysis
Grys M , Pieniazek I , Walczak J , Debray R , Cybulski J , Przygodzki |